Tenormin: Effective Blood Pressure and Angina Control
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.51 | $45.12 (0%) | 🛒 Add to cart |
| 20 | $2.51 | $90.25 $50.14 (44%) | 🛒 Add to cart |
| 30 | $2.17 | $135.37 $65.18 (52%) | 🛒 Add to cart |
| 60 | $1.00 | $270.75 $60.17 (78%) | 🛒 Add to cart |
| 90 | $0.84 | $406.12 $75.21 (81%) | 🛒 Add to cart |
| 120 | $0.75 | $541.50 $90.25 (83%) | 🛒 Add to cart |
| 180 | $0.67 | $812.25 $120.33 (85%) | 🛒 Add to cart |
| 270 | $0.59 | $1218.37 $160.44 (87%) | 🛒 Add to cart |
| 360 | $0.54
Best per pill | $1624.50 $195.54 (88%) | 🛒 Add to cart |
Tenormin (atenolol) is a cardioselective beta-blocker medication prescribed for the management of hypertension (high blood pressure) and angina pectoris (chest pain). It functions by blocking the action of certain natural chemicals in the body, such as epinephrine, on the heart and blood vessels. This action results in a slower heart rate, reduced force of heart muscle contraction, and relaxed blood vessels, which collectively lower blood pressure and decrease the heart’s demand for oxygen, thereby preventing angina attacks. It is a cornerstone in cardiovascular therapeutic regimens, valued for its predictable pharmacokinetic profile and well-established efficacy in long-term management.
Features
- Active pharmaceutical ingredient: Atenolol
- Drug class: Cardioselective beta-1-adrenergic receptor blocking agent
- Standard available dosages: 25 mg, 50 mg, and 100 mg film-coated tablets
- Administration: Oral, typically once daily
- Bioavailability: Approximately 50%
- Protein binding: Less than 5%
- Half-life: 6-7 hours
- Primary excretion route: Renal
Benefits
- Provides consistent 24-hour blood pressure control with a convenient once-daily dosing schedule for many patients, supporting treatment adherence.
- Effectively reduces the frequency and severity of angina attacks, improving exercise tolerance and quality of life.
- Lowers the heart’s oxygen demand, offering protective cardiac effects, especially during physical exertion or stress.
- Demonstrates a cardioselective action at therapeutic doses, primarily blocking beta-1 receptors in the heart, which can minimize certain side effects associated with non-selective beta-blockers.
- Has a well-documented safety and efficacy profile based on decades of widespread clinical use and research.
- Can be used as part of a comprehensive management strategy following a heart attack to improve survival and reduce the risk of subsequent cardiovascular events.
Common use
Tenormin is primarily indicated for the management of hypertension, either as monotherapy or in combination with other antihypertensive agents such as thiazide diuretics. It is also approved for the long-term management of chronic stable angina pectoris. Furthermore, it is utilized in the secondary prevention of cardiovascular mortality and morbidity following an acute myocardial infarction (heart attack), once the patient’s clinical condition is stable. Its use is predicated on a confirmed diagnosis by a healthcare professional, and it is not intended for the immediate relief of acute angina attacks, for which sublingual nitroglycerin remains the standard.
Dosage and direction
Dosage is highly individualized and must be determined by a physician based on the patient’s clinical condition, renal function, and treatment response.
- Hypertension: The usual initial dose is 50 mg administered orally once daily. This may be increased to 100 mg once daily after one to two weeks if an adequate response is not achieved. A single daily dose of 100 mg is typically the maximum recommended for hypertension.
- Angina Pectoris: The usual initial dose is 50 mg orally once daily. This may be increased to 100 mg once daily after one week if an optimal therapeutic response has not been achieved. Some patients may be maintained on 25 mg once daily.
- Post-Myocardial Infarction: Therapy with 50 mg or 100 mg daily is often initiated and continued for at least one to three years post-infarction, depending on the patient’s overall risk profile.
- Renal Impairment: Dosage adjustment is necessary for patients with significantly impaired renal function (creatinine clearance < 35 mL/min/1.73m²). A reduced dose of 25 mg or 50 mg every 24-48 hours is recommended, guided by the patient’s creatinine clearance levels.
The tablet should be swallowed whole with a glass of water, with or without food, though consistency in administration relative to meals is advised. It is crucial not to abruptly discontinue Tenormin therapy, as this can precipitate a rebound phenomenon including worsening angina, hypertension, or myocardial infarction. Discontinuation should be gradual, typically over a period of one to two weeks, under direct medical supervision.
Precautions
Patients should exercise several precautions while on Tenormin therapy. It can mask the tachycardic symptoms of hypoglycemia (e.g., palpitations) in diabetic patients, though sweating and dizziness may still occur. It may also potentiate insulin-induced hypoglycemia and delay recovery of blood sugar levels. Caution is advised in patients with a history of severe anaphylactic reactions to various allergens, as Tenormin may blunt the effectiveness of epinephrine used to treat such reactions. It can reduce intraocular pressure, potentially interfering with glaucoma screening. Patients should inform their surgeon or dentist that they are taking a beta-blocker before any surgical procedure. Regular monitoring of heart rate, blood pressure, and, in patients with diabetes, blood glucose is essential. Use with caution in patients with compensated heart failure, as beta-blockers can depress myocardial contractility.
Contraindications
Tenormin is contraindicated in several patient populations and conditions due to the potential for severe adverse reactions. Absolute contraindications include sinus bradycardia (abnormally slow heart rate), second- or third-degree heart block (without a functioning permanent pacemaker), cardiogenic shock, overt cardiac failure requiring intensive IV inotropic support, and sick sinus syndrome. It is also contraindicated in patients with a known hypersensitivity to atenolol or any component of the formulation. Significant hypotension (very low blood pressure) is another key contraindication for initiating therapy.
Possible side effect
As with all medications, Tenormin can cause side effects, although not everybody gets them. The most common side effects are related to its pharmacological action and are often dose-dependent.
- Very common (≥1/10): Cold extremities (hands and feet), bradycardia (slow heart rate).
- Common (≥1/100 to <1/10): Dizziness, fatigue, lethargy, diarrhea, nausea.
- Uncommon (≥1/1,000 to <1/100): Sleep disturbances, nightmares, dyspnea (shortness of breath), wheezing (more likely in predisposed patients), palpitations, heart failure, heart block, postural hypotension, Raynaud’s phenomenon, vomiting, constipation, dry mouth, rash, pruritus (itching).
- Rare (≥1/10,000 to <1/1,000): Hallucinations, mood changes, confusion, memory loss, psoriasiform rash or exacerbation of psoriasis, alopecia (hair loss), dry eyes, visual disturbances, thrombocytopenia (low platelet count).
- Very rare (<1/10,000): Peyronie’s disease.
Drug interaction
Tenormin can interact with numerous other medications, which may alter its effects or increase the risk of serious side effects.
- Other antihypertensives: Concomitant use with other blood pressure-lowering drugs (e.g., calcium channel blockers like verapamil or diltiazem, alpha-blockers, other beta-blockers) can lead to additive hypotensive and bradycardic effects.
- Antiarrhythmics: Drugs such as disopyramide, amiodarone, and propafenone can potentiate negative inotropic and chronotropic effects, increasing the risk of bradycardia and heart block.
- Cardiac glycosides (e.g., Digoxin): Concurrent use increases the risk of severe bradycardia.
- Insulin and oral hypoglycemics: Beta-blockers can mask hypoglycemic symptoms and may enhance the glucose-lowering effect.
- NSAIDs: Non-steroidal anti-inflammatory drugs like indomethacin may antagonize the antihypertensive effect of beta-blockers.
- Sympathomimetics: Drugs that stimulate the sympathetic nervous system (e.g., epinephrine, pseudoephedrine, decongestants) may have their effects counteracted, or conversely, unopposed alpha-adrenergic activity can lead to severe hypertension.
- Clonidine: Abrupt withdrawal of clonidine in patients taking a beta-blocker can exacerbate rebound hypertension. Beta-blocker withdrawal should precede clonidine withdrawal.
- MAOIs: Monoamine oxidase inhibitors are generally not recommended for use with beta-blockers.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered on the same day. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Patients should never take a double dose to make up for a forgotten one, as this could significantly increase the risk of adverse effects like severe bradycardia or hypotension. Maintaining a consistent daily routine is key to the effectiveness of this medication.
Overdose
Overdose with Tenormin is characterized by excessive beta-blockade and can be life-threatening. Key signs and symptoms include severe bradycardia (very slow heart rate), hypotension (profound low blood pressure), heart failure, bronchospasm (wheezing, difficulty breathing), and hypoglycemia. In severe cases, cardiac arrest may occur. Management is supportive and requires urgent medical attention. Treatment may include gastric lavage or activated charcoal if ingestion was recent. Atropine is administered for bradycardia. For refractory bradycardia and hypotension, intravenous glucagon, beta-adrenergic agonists like dobutamine or isoprenaline, or cardiac pacing may be necessary. Blood glucose should be monitored and corrected if low.
Storage
Tenormin tablets should be stored in their original container at room temperature, between 15°C and 30°C (59°F and 86°F). The medication must be kept in a dry place, protected from light and moisture, and out of reach of children and pets. Do not store it in a bathroom or near a sink. Do not use the medicine after the expiration date printed on the packaging. Unused medication should be disposed of properly via a pharmacy take-back program and should not be flushed down the toilet or thrown in household trash.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The content provided has been compiled from various pharmacological references but may not cover all possible uses, directions, precautions, interactions, or adverse effects.
Reviews
- Dr. Eleanor Vance, Cardiologist: “Atenolol remains a fundamental agent in my practice for hypertension and stable angina. Its once-daily dosing and predictable effect profile make it a reliable choice for long-term management, particularly in patients with good renal function. I find patient adherence is generally high.”
- Clinical Pharmacist Review: “From a pharmacokinetic standpoint, Tenormin’s hydrophilic nature and renal excretion profile make it less likely to cause CNS side effects like sleep disturbances compared to more lipophilic beta-blockers. However, this necessitates careful dose adjustment in renal impairment. It’s a workhorse drug with a very well-understood interaction profile.”
- Patient Experience (Hypertension): “I’ve been on 50mg for three years now. It brought my blood pressure down to normal levels within weeks. The only side effect I noticed was my hands feeling a bit colder in winter, but it’s a small price to pay for being well-controlled.”
- Patient Experience (Angina): “Before starting Tenormin, I couldn’t walk to the mailbox without chest tightness. Now, on 50mg daily, I can enjoy walks with my dog again. It’s given me my freedom back. I did feel tired for the first month, but that faded.”